Bluejay Therapeutics is planning an IPO in the US, targeting $150 million.
Daily NewsInvesting.com -- Bluejay Therapeutics, a pharmaceutical company specializing in severe viral and liver diseases, is reportedly planning an initial public offering...
Read More